Across TCGA pan-cancer cohorts, LSP1P1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LSP1P1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LSP1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LSP1P1 is over-expressed in tumor.
KIRC and LUAD are the cancer types where LSP1P1 tumor–normal differential expression is most reproducible.